Skip to main content

Prophylactic use of antibiotics for prevention of meningococcal infections: systematic review and meta-analysis of randomised trials

European Journal of Clinical Microbiology and Infectious Diseases volume 24, pages 172–181 (2005)Cite this article

Abstract

A systematic review and meta-analysis of randomised controlled trials was performed in order to study the effectiveness of prophylactic treatment regimens in preventing secondary cases of meningococcal disease (i.e., those contracted after contact with a person with meningococcal disease) and in eradicating Neisseria meningitidis from the pharynx of healthy colonised individuals. The Medline, Embase, and Lilacs databases, the Cochrane Library, and the references of all studies identified were systematically searched for relevant trials. Two reviewers independently applied selection criteria, performed quality assessment, and selected data. Relative risks were pooled using a fixed effects model unless heterogeneity assessed by the I2 statistic and chi-square test was found. In such cases, a random effect model was used. There were no cases of meningococcal disease following treatment with antibiotics or placebo, thus effectiveness regarding prevention of future disease could not be directly assessed. Compared with placebo, ciprofloxacin (RR = 0.04; 95%CI, 0.01–0.12), rifampin (RR = 0.17; 95%CI, 0.12–0.24), minocycline (RR = 0.30; 95%CI, 0.19–0.45), and penicillin (RR = 0.47; 95%CI, 0.24–0.94), proved effective at eradicating Neisseria meningitidis 1 week after treatment. After 1–2 weeks, only ciprofloxacin (RR = 0.03; 95%CI, 0.00–0.42) and rifampin (RR = 0.20; 95%CI, 0.14–0.29) still proved significantly effective when compared with placebo. Rifampin continued to be effective (RR = 0.24; 95%CI, 0.16–0.37) compared with placebo until up to 4 weeks post treatment. Rifampin was the only drug to which resistance developed. Given that the use of rifampin in an outbreak setting might lead to the circulation of isolates resistant to rifampin, the use of ciprofloxacin and ceftriaxone should be considered.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Ferguson LE, Hormann MD (2002) Neisseria meningitidis: presentation, treatment and prevention. J Pediatr Health Care 16:119–124

    Google Scholar 

  2. Bramley JC, Begg NT, Booy R, Buttery J, Finn A, Heath PT, Jones IG, Richmond PC, Rosenstein NE (1999) Conjugate vaccines for preventing meningococcal C meningitis and septicaemia. Cochrane database of systematic reviews, 1999, issue 4, article no. CD001834. DOI 10.1002/14651858.CD001834

  3. Hanford S, Ramsay M, Fox A, and the Surveillance Network for Invasive Neisseria meningitidis in Europe. Final report, 1999 & 2000. Commission of the European Communities. http://www.euibis.org/documents/meningo19992000.pdf

  4. Andersen J, Berthelsen L, Jensen BB et al (2000) Surveillance of cases of meningococcal disease associated with military recruits studied for meningococcal carriage. Scand J Infect Dis 32:527–531

    Google Scholar 

  5. World Health Organization. Meningococcal disease. http://www.who.int/csr/disease/meningococcal/en/. Cited 30 May 2004

  6. Public Health Laboratory Service Meningococcus Forum (2002) Guidelines for public health management of meningoccocal disease in the UK. Commun Dis Public Health 5:187–204

    Google Scholar 

  7. Girgis N, Sultan Y, Frenck RW Jr et al (1998) Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatr Infect Dis J 17:816–819

    Google Scholar 

  8. Centers for Disease Control and Prevention (2000) Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR. Recomm Rep 49(RR07):1–10

    Google Scholar 

  9. Fraser A, Gafter-Gvili A, Paul M, Leibovici L (2005) Antibiotics for preventing meningococcal infections. Cochrane database of systematic reviews, 2005, issue 1, article no. CD004785. DOI 10.1002/14651858.CD004785.pub2

  10. Gaunt PN (1988) Ciprofloxacin vs ceftriaxone for eradication of meningococcal carriage. Lancet ii(8604):218–219

    Google Scholar 

  11. Wall AR, Grunberg RN (1982) Rifampicin and erythromycin for the meningococcal carrier. Lancet ii(8311):1346

    Google Scholar 

  12. Artenstein MS, Lamson TH, Evans JR (1967) Attempted prophylaxis against meningococcal infection using intramuscular penicillin. Mil Med 132:1009–1011

    Google Scholar 

  13. Cardenas AT, Contreras AG, Rojas CQ (1995) Cefixima para quimioprofilaxis antimeningococica [Cefixime in meningococcal disease chemoprophylaxis]. Rev Chil Pediatr 66:217–219

    Google Scholar 

  14. Fairbrother RW (1940) Cerebrospinal meningitis: the use of sulphonamide derivatives in prophylaxis. Brit Med J 2:859–862

    Google Scholar 

  15. Gilja OH, Halstensen A, Digranes A et al (1993) Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis. Antimicrob Agents Chemother 37:2024–2026

    Google Scholar 

  16. Halstensen A, Gilja OH, Digranes A et al (1995) Single-dose ofloxacin in the eradication of pharyngeal carriage of Neisseria meningitidis. Drugs 49(Suppl 2):399–400

    Google Scholar 

  17. Sanders E (1967) Use of sulfonamide carbonic anhydrase inhibitors in treatment of meningococcal carriers: rationale and report of a clinical trial of ethoxzolamide. Am J Med Sci 254:709–716

    Google Scholar 

  18. Shehab S, Leitner L, Bogokowsky B et al (1991) Alternating rifampicin and ceftriaxone for Neisseria meningitidis eradication in contacts. Harefuah 120:641–643

    Google Scholar 

  19. Potter PC, Frasch CE, van der Sande WJ et al (1990) Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement. J Infect Dis 161:932–937

    Google Scholar 

  20. Band JD, Fraser DW (1984) Adverse effects of two rifampicin dosage regimens for the prevention of meningococcal infection. Lancet i(8368):101–102

    Google Scholar 

  21. Beam WE Jr, Newberg NR, Devine LF et al (1971) The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population. J Infect Dis 124:39–46

    Google Scholar 

  22. Beaty HN (1983) Rifampin and minocycline in meningococcal disease. Rev Infect Dis 5(Suppl 3):S451–S458

    Google Scholar 

  23. Chapalain JC, Guibourdenche M, Perrier Gros Claude JD et al (1992) The chemoprophylaxis of cerebrospinal meningitis using rifampin in a military population. Pathol Biol 40:230–233

    Google Scholar 

  24. Cheever FS, Breeses BB, Upham HC (1943) The treatment of meningococcus carriers with sulfadiazine. Ann Int Med 19:602–608

    Google Scholar 

  25. Devine LF, Springer GL, Frazier WE et al (1972) Selective minocycline and rifampin treatment of group C meningococcal carriers in a new naval recruit camp. Am J Med Sci 263:79–93

    Google Scholar 

  26. Devine LF, Pollard RB, Krumpe PE et al (1973) Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers. Am J Epidemiol 97:394–401

    Google Scholar 

  27. Gonzalez de Aledo Linos A, Garcia Merino J (2000) Control de un brote escolar de enfermedad meningococica serogrupo B mediante quimioprofilaxis con azitromicina y ciprofloxacino [Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin]. An Esp Pediatr 53:412–417

    Google Scholar 

  28. Gray FC, Gear J (1941) Sulphapyridine M & B 693 as a prophylactic against cerebrospinal meningitis. South Afr Med J 15:139–140

    Google Scholar 

  29. Kuhns DM, Nelson CT, Feldman HA, Kuhn LR (1943) The prophylactic value of sulfadiazine. JAMA 123:335–339

    Google Scholar 

  30. Sivonen A, Renkonen OV, Weckstrom P et al (1978) The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland. J Infect Dis 137:238–244

    Google Scholar 

  31. Weidmer CE, Dunkel TB, Pettyjohn FS et al (1971) Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: emergence of resistant strains. J Infect Dis 124:172–178

    Google Scholar 

  32. Hart CA, Cuevas LE, Kazembe P et al (1992) The use of ciprofloxacin to eradicate oropharyngeal carriage of Neisseria meningitidis: a preliminary report. Adv Antimicr Antineopl Chemother 11:167–171

    Google Scholar 

  33. Schwartz B (1991) Chemoprophylaxis for bacterial infections: principles of and application to meningoccocal infections. Rev Infect Dis 13(Suppl 2):S170–S173

    Google Scholar 

  34. Simmons G, Jones N, Calder L (1999) Comparison of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis. Aust N Z J Med 29:587

    Google Scholar 

  35. Blakebrough IS, Gilles HM (1980) The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria. J Infect 2:137–143

    Google Scholar 

  36. Cuevas LE, Kazembe P, Mughogho GK et al (1995) Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin. J Infect Dis 171:728–731

    Google Scholar 

  37. Borgono JM, Rodriguez H, Garcia J et al (1981) Eficacia de la rifampicina en el tratamiento de los portadores de meningococo [Efficacy of rifampicin in the treatment of meningococcus carriers]. Rev Chil Pediatr 52:146–148

    Google Scholar 

  38. Deal WB, Sanders E (1969) Efficacy of rifampin in treatment of meningococcal carriers. N Engl J Med 281:641–645

    Google Scholar 

  39. Deal WB, Sanders E (1969) Therapeutic trial of cephalexin in meningococcal carriers. Antimicrob Agents Chemother 9:441–444

    Google Scholar 

  40. Deviatkina NP, Demina AA, Orlova EV (1978) Otsenka saniruiushchego deistviia rifampitsina na nositel’stvo meningokokkov [Evaluation of the sanative action of rifampicin on the meningococcal carrier state]. Antibiotiki 23:794–797

    Google Scholar 

  41. Devine LF, Johnson DP, Hagerman CR et al (1970) Rifampin levels in serum and saliva and effect on the meningoccocal carrier state. JAMA 214:1055–1059

    Google Scholar 

  42. Devine LF, Johnson DP, Hagerman CR et al (1971) The effect of minocycline on meningococcal nasopharyngeal carrier state in naval personnel. Am J Epidemiol 93:337–345

    Google Scholar 

  43. Devine LF, Johnson DP, Hagerman CR (1970) The effect of coumermycin A on the meningococcal carrier state. Am J Med Sci 260:165–170

    Google Scholar 

  44. Dowd JM, Blink D, Miller CH et al (1966) Antibiotic prophylaxis of carriers of sulfadiazine-resistant meningococci. J Infect Dis 116:473–480

    Google Scholar 

  45. Dworzack DL, Sanders CC, Horowitz EA et al (1988) Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers. Antimicrob Agents Chemother 32:1740–1741

    Google Scholar 

  46. Edwards LD, Gartner T (1984) Comparison between bacampicillin and amoxycillin in treating genital and extragenital infection with Neisseria gonorrhoeae and pharyngeal infection with Neisseria meningitidis. Br J Vener Dis 60:380–383

    Google Scholar 

  47. Guttler RB, Counts GW, Avent CK et al (1971) Effect of rifampin and minocycline on meningococcal carrier rates. J Infect Dis 124:199–205

    Google Scholar 

  48. Judson FN, Ehret JM (1984) Single-dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis. Lancet ii(8417-8):1462–1463

    Google Scholar 

  49. Kaiser AB, Hennekens CH, Saslaw MS et al (1974) Seroepidemiology and chemoprophylaxis of disease due to sulfonamide-resistant Neisseria meningitidis in a civilian population. J Infect Dis 130:217–224

    Google Scholar 

  50. Kaya A, Tasyaran MA, Celebi S et al (1997) Efficacy of a single dose of ciprofloxacin vs. rifampicin in eradicating the nasopharyngeal carriage of Neisseria meningitidis. Turk J Med Sci 27:153–155

    Google Scholar 

  51. Munford RS, de Vasconcelos ZJS, Philips CJ et al (1974) Eradication of carriage of Neisseria meningitidis in families: a study in Brazil. J Infect Dis 129:644–649

    Google Scholar 

  52. Pugsley MP, Dworzack DL, Sanders CC et al (1984) Evaluation of Sch 29,482 in the eradication of Neisseria meningitidis from nasopharyngeal carriers. Antimicrob Agents Chemother 25:494–496

    Google Scholar 

  53. Pugsley MP, Dworzack DL, Horowitz EA et al (1987) Efficacy of ciprofloxacin in the treatment of nasopharyngeal carriers of Neisseria meningitidis. J Infect Dis 156:211–213

    Google Scholar 

  54. Renkonen OV, Sivonen A, Visakorpi R (1987) Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland. Antimicrob Agents Chemother 31:962–963

    Google Scholar 

  55. Schwartz B, Al Tobaiqi A, Al Ruwais A et al (1988) Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet i(8597):1239–1242

    Google Scholar 

  56. Simmons G, Jones N, Calder L (2000) Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis. J Antimicrob Chemother 45:909–911

    Google Scholar 

  57. Purcell B, Samuelsson S, Hahne SJ, Ehrhard I, Heuberger S, Camaroni I, Charlett A, Stuart JM (2004) Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. BMJ 328:1339–1343

    Google Scholar 

  58. Hart CA, Rogers TRF (1993) Meningococcal disease. J Med Microbiol 39:3–25

    Google Scholar 

  59. Carter PE, Abadi FJ, Yakubu DE et al (1994) Molecular characterization of rifampin-resistant Neisseria meningitidis. Antimicrob Agents Chemother 38:1256–1261

    Google Scholar 

Download references

Acknowledgements

We thank the Cochrane Acute Respiratory Infections Group. This research was supported through a project grant from the Israel National Institute for Health Policy and Health Services Research

Author information

Affiliations

  1. Department of Medicine E, Rabin Medical Center, Beilinson Campus, Petah-Tiqva, 49100, Israel

    A. Fraser, A. Gafter-Gvili, M. Paul & L. Leibovici

  2. Infectious Diseases Unit, Rabin Medical Center, Beilinson Campus, Petah-Tiqva, 49100, Israel

    M. Paul

  3. Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, 69978, Israel

    L. Leibovici

Authors
  1. A. Fraser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Gafter-Gvili
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Leibovici
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Fraser.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fraser, A., Gafter-Gvili, A., Paul, M. et al. Prophylactic use of antibiotics for prevention of meningococcal infections: systematic review and meta-analysis of randomised trials. Eur J Clin Microbiol Infect Dis 24, 172–181 (2005). https://doi.org/10.1007/s10096-005-1297-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-005-1297-7

Keywords

  • Ceftriaxone
  • Minocycline
  • Rifampin
  • Meningococcal Disease
  • Neisseria Meningitidis